Medicare Enrolled
Dr. Firas Akhrass, MD
Endocrinology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Akhrass from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akhrass? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akhrass
Dr. Firas Akhrass is an endocrinology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Akhrass performed 32,620 Medicare services across 17,793 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akhrass received a total of $770,968 from 77 pharmaceutical and/or device companies across 3124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akhrass is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in TX$ $770,968 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,620
Medicare services
Top 1% in TX for endocrinology
17,793
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,631 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 3,324 | $6 | $6 |
| Office visit, established patient (30-39 min) | 3,168 | $88 | $209 |
| Comprehensive metabolic blood panel | 2,809 | $10 | $29 |
| Hemoglobin A1c test (diabetes monitoring) | 2,580 | $9 | $27 |
| Thyroid stimulating hormone (TSH) test | 2,343 | $16 | $46 |
| Lipid panel (cholesterol and triglycerides) | 2,271 | $13 | $37 |
| Complete blood count (CBC) with differential | 2,083 | $8 | $21 |
| Free thyroxine (T4) test | 1,618 | $9 | $25 |
| Parathyroid hormone level test | 1,383 | $40 | $113 |
| Vitamin D level test | 1,288 | $29 | $75 |
| Ferritin level test (iron stores) | 951 | $13 | $37 |
| Vitamin B-12 level test | 943 | $15 | $41 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 844 | $26 | $87 |
| Folic acid level test | 828 | $14 | $40 |
| Glycated protein level | 540 | $16 | $41 |
| C-peptide (protein) level | 539 | $20 | $57 |
| Urine microalbumin test (kidney screening) | 420 | $6 | $15 |
| Creatinine test (kidney function) | 419 | $5 | $14 |
| Office visit, established patient (20-29 min) | 386 | $59 | $142 |
| Ultrasound scan of head and neck soft tissue | 312 | $79 | $223 |
| Sex hormone binding globulin (protein) level | 263 | $21 | $60 |
| Bone density scan (DEXA) | 239 | $37 | $78 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 219 | $30 | $79 |
| Phosphate level test | 198 | $5 | $13 |
| Basic metabolic blood panel | 170 | $8 | $23 |
| Drug injection, under skin or into muscle | 149 | $10 | $49 |
| PSA test (prostate cancer screening) | 136 | $18 | $50 |
| Uric acid level test | 135 | $4 | $12 |
| Cortisol (hormone) measurement, total | 134 | $15 | $45 |
| Thyroglobulin (thyroid protein) antibody measurement | 133 | $16 | $44 |
| Microsomal antibodies (autoantibody) measurement | 120 | $14 | $40 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 116 | $10 | $25 |
| Complete ultrasound study of arm and leg arteries | 110 | $91 | $262 |
| Creatine kinase (cardiac enzyme) level, total | 105 | $6 | $18 |
| Testing of autonomic (sympathetic) nervous system function | 101 | $94 | $270 |
| New patient office visit (45-59 min) | 94 | $113 | $319 |
| Thyroid hormone, t3 measurement, free | 84 | $17 | $46 |
| Office visit, established patient, complex (40-54 min) | 83 | $130 | $282 |
| Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | 76 | $96 | $296 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 68 | $22 | $45 |
| Flu vaccine administration | 68 | $29 | $30 |
| Kidney function blood test panel | 67 | $8 | $24 |
| Adrenocorticotropic hormone (acth) level | 64 | $37 | $106 |
| Urinalysis with microscopic exam | 59 | $3 | $9 |
| Measurement of liver stiffness | 53 | $21 | $120 |
| Ultrasound scan of organ tissue for measuring elasticity | 52 | $78 | $203 |
| Ldl cholesterol level | 52 | $10 | $26 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 49 | $104 | $296 |
| Prolactin (milk producing hormone) level | 43 | $19 | $53 |
| Sed rate test (inflammation marker) | 38 | $3 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 35 | $1 | $20 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 32 | $18 | $51 |
| Gonadotropin, luteinizing (reproductive hormone) level | 32 | $18 | $51 |
| Dehydroepiandrosterone (dhea-s) hormone level | 29 | $22 | $61 |
| Blood glucose (sugar) measurement using reagent strip | 26 | $5 | $9 |
| Liver function blood test panel | 21 | $8 | $22 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 19 | $13 | $36 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 16 | $31 | $54 |
| New patient office visit, complex (60-74 min) | 16 | $118 | $402 |
| Ketone bodies analysis, qualitative | 15 | $4 | $12 |
| Ultrasound study of arm and leg arteries | 15 | $59 | $168 |
| Office visit, established patient (10-19 min) | 13 | $44 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $73 | $127 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 11 | $99 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$770,968
Total received (2018-2024)
Avg $128,495/year across 6 years
Top 3% in TX for endocrinology
77
Companies
3,124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$741,855 (96.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,066 (2.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,048 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$134,369
2023$115,475
2022$157,836
2020$75,577
2019$133,840
2018$153,870
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$259,884
Novo Nordisk Inc
$111,008
Corcept Therapeutics
$68,730
AstraZeneca Pharmaceuticals LP
$55,465
Amgen Inc.
$35,107
Boehringer Ingelheim Pharmaceuticals, Inc.
$32,349
Mannkind Corporation
$30,841
Xeris Pharmaceuticals, Inc.
$24,431
Janssen Pharmaceuticals, Inc
$24,044
Amarin Pharma Inc.
$21,473
Merck Sharp & Dohme Corporation
$16,757
MannKind Corporation
$15,995
Madrigal Pharmaceuticals
$11,469
Tandem Diabetes Care, Inc.
$10,038
Dexcom, Inc.
$9,478
Strongbridge US INC.
$8,883
CeQur Corporation
$8,864
Esperion Therapeutics, Inc.
$6,628
Bayer HealthCare Pharmaceuticals Inc.
$3,514
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,935
Abbott Laboratories
$1,594
SANOFI-AVENTIS U.S. LLC
$1,461
Radius Health, Inc.
$1,277
Medtronic, Inc.
$1,235
Novartis Pharmaceuticals Corporation
$1,174
Ascensia Diabetes Care Us Inc.
$859
Medtronic MiniMed, Inc.
$656
Antares Pharma, Inc.
$517
Valeritas, Inc.
$490
Bayer Healthcare Pharmaceuticals Inc.
$371
AbbVie Inc.
$326
Allergan Inc.
$304
Insulet Corporation
$283
ABBVIE INC.
$267
AbbVie, Inc.
$260
Becton, Dickinson and Company
$203
KVK-Tech, Inc.
$197
OPKO Pharmaceuticals, LLC
$195
Companion Medical, Inc.
$192
BETA BIONICS, INC.
$190
AKRIMAX PHARMACEUTICALS, LLC
$186
Allergan, Inc.
$155
Regeneron Healthcare Solutions, Inc.
$149
Sequel Med Tech, LLC
$128
Ultragenyx Pharmaceutical Inc.
$114
Kyowa Kirin, Inc.
$112
Zealand Pharma US, Inc.
$111
RECORDATI_RARE_DISEASES_INC.
$108
PFIZER INC.
$73
Tolmar, Inc.
$66
Eisai Inc.
$60
Merck Sharp & Dohme LLC
$57
Acerus Pharmaceuticals Corporation
$57
Organogenesis Inc.
$55
Shire North American Group Inc
$50
Nalpropion Pharmaceuticals LLC
$48
Bigfoot Biomedical Inc
$42
VIVUS, Inc.
$41
Amphastar Pharmaceuticals, Inc.
$39
IBSA Pharma Inc.
$38
Orexigen Therapeutics, Inc.
$31
Nalpropion Pharmaceuticals, Inc.
$29
Alexion Pharmaceuticals, Inc.
$28
Almatica Pharma LLC
$24
Roche Diabetes Care, Inc.
$24
LifeScan, Inc.
$22
Chiesi USA, Inc.
$22
GRT US Holding, Inc.
$20
Nestle HealthCare Nutrition Inc.
$19
Supernus Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$18
Horizon Therapeutics plc
$17
VIVUS LLC
$15
LIFESCAN, INC.
$15
Ipsen Biopharmaceuticals, Inc
$14
Kowa Pharmaceuticals America, Inc.
$11
Echosens North America, Inc.
$8
Top 3 companies account for 57.0% of total payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · BYSTOLIC · Belviq · CHANTIX · CONTRAVE · CYCLOSET · Cables · CeQur Simplicity · Creon · Crysvita · Cryvista · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVKEEZA · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LEQVIO · LINZESS · LOKELMA · Levemir · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · Natesto · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim Family of SCS IPGs · Prolia · Puraply · QSYMIA · QULIPTA · Qutenza · RAYALDEE · RECORLEV · RESMETIROM · REZDIFFRA · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Software · Sogroya · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VANTA ADAPTIVESTIM · VIBERZI · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZAVZPRET · ZEGALOGUE · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for endocrinology in TX.
Equivalent to $2,363 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
62
Per 100K population
3.0
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Akhrass is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Akhrass experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Akhrass performed 3,324 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akhrass receive payments from pharmaceutical companies?
Yes. Dr. Akhrass received a total of $770,968 from 77 companies across 3,124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akhrass's costs compare to other endocrinologys in San Antonio?
Dr. Akhrass's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akhrass) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in San Antonio
Browse endocrinologys in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in TX
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in TX
Which TX endocrinologys receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology